DiscoverP4A Let's Talk Rare: The Life Science PodcastSpecial episode - Bluebird Bio: What went wrong? -December 2021:
Special episode - Bluebird Bio: What went wrong? -December 2021:

Special episode - Bluebird Bio: What went wrong? -December 2021:

Update: 2021-12-13
Share

Description

Sophie Schmitz and Joanna Fernandes discuss bluebird bio’s innovative gene therapy Zynteglo and its withdrawal from the European market. Sophie and Joanna will be looking at the fall of Zynteglo from two sides: from a company perspective and from the perspective of the EU environment.


Presenter: Georgie Rack, Communication Executive


Contributors: Sophie Schmitz, Managing Partner and Joanna Fernandes, Senior Consultant


Producer: Operations team

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Special episode - Bluebird Bio: What went wrong? -December 2021:

Special episode - Bluebird Bio: What went wrong? -December 2021:

Partners4Access